New method of treatment of blood cancer


New method of treatment of blood cancer

Leukemia is a disease dangerous to the lives of patients. Recently, we have tested the new method in the treatment of this disease. It is a combination a inhibitors protesome as bortezomib with a mitotic inhibitor as alvocidib.

This result was published in the scientific journal Clinical Cancer Research by scientists from Virginia Commonwealth University. Accordingly, we conducted tests on 16 patients with blood cancers as Hodgkin the treatment adding alvocidib drug regimen on day 1 and day 8 of the first transmission bortezomib. Results showed that the majority of patients are progressing well.

TS. Beata Holkova, co-authored the study, said the testing of patients respond well to treatment. It is unique patients who have been resistant to this treatment alone, there are good results. From the results of this study, we absolutely can find new blood cancer treatment regimens.

(According to ScienceDaily, 6/2011